English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The current review aims to systematically assess the osteogenic capacity of gingiva-derived mesenchymal stem cells (GMSCs) in preclinical studies. A comprehensive electronic search of PubMed, Embase, Web of Science, and Scopus databases, as well as a manual search of relevant references, was performed in June 2020 without date or language restrictions. Eligibility criteria were the following: studies that compared mesenchymal stem cells (MSCs) derived from the gingiva with other MSC sources ( in vitro  or  in vivo ) or cell-free scaffold ( in vivo ) and studies that reported at least one of the following outcomes: osteogenic potential and new bone formation for  in vitro  and  in vivo , respectively. Moreover, the assessment of included studies was conducted using appropriate guidelines. From 646 initial retrieved studies, 35 full-text articles were subjected to further screening and 26 studies were selected (20  in vitro  studies and 6  in vivo  studies). GMSCs showed great proliferation capacity and expressed recognized mesenchymal stem cell markers, particularly CD90.  In vitro , MSC sources including GMSCs were capable of undergoing osteogenic differentiation with less ability in GMSCs, while most  in vivo  studies confirmed the capacity of GMSCs to regenerate bony defects. Concerning the assessment of methodological quality,  in vitro  studies met the relevant guideline except in five areas: the sample size calculation, randomization, allocation concealment, implementation, and blinding, and  in vivo  publications had probably low risk of bias in most domains except in three areas: allocation concealment, attrition, and blinding items.

stem cells international

The Gingiva from the Tissue Surrounding the Bone to the Tissue Regenerating the Bone: A Systematic Review of the Osteogenic Capacity of Gingival Mesenchymal Stem Cells in Preclinical Studies